Evidence map›Paper›PMID 36010326›Full record

ArticleDiagnostics (Basel, Switzerland)2022

New RAPMYCOI Sensititre

Anna Borek, Anna Zabost, Agnieszka Głogowska, Dorota Filipczak, Ewa Augustynowicz-Kopeć

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. First report ofJournal of veterinary research · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna BorekDepartment of Microbiology National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Anna ZabostDepartment of Microbiology National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.ORCID 0000-0003-2781-9844
Agnieszka GłogowskaDepartment of Microbiology National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.ORCID 0000-0003-1296-4934
Dorota FilipczakDepartment of Microbiology National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Ewa Augustynowicz-KopećDepartment of Microbiology National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.ORCID 0000-0001-6162-8748

Funding

This research was funded by the statutory activity of National Tuberculosis and Lung Diseases Research Institute, Task No 1.8/2019
6 · The paper itself

Abstract

Rapidly growing mycobacteria (RGM) cause an increasing international concern, mainly due to their natural resistance to many antibiotics. The aim of this study was to conduct species identification and determine the antimicrobial susceptibility profiles of RGM isolated in Poland. Antimicrobial susceptibility was tested using broth microdilution and the RAPMYCOI panel. A total of 60 strains were analysed, including the following species:

Indexed as

antimicrobial resistancebroth microdilutionminimal inhibitory concentration (MIC)rapidly growing mycobacteria

Identifiers

PMID36010326
PMCPMC9407062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.